PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,033,000 | +176.2% | 96,000 | +2894.4% | 0.15% | +166.1% |
| Q2 2015 | $374,000 | -53.9% | 3,206 | -6.8% | 0.06% | -50.9% |
| Q1 2015 | $812,000 | +83.7% | 3,441 | +47.3% | 0.11% | +78.1% |
| Q4 2014 | $442,000 | -20.6% | 2,336 | 0.0% | 0.06% | -24.7% |
| Q3 2014 | $557,000 | +76.8% | 2,336 | -51.0% | 0.08% | +84.8% |
| Q2 2014 | $315,000 | -32.1% | 4,770 | +7.0% | 0.05% | -32.4% |
| Q1 2014 | $464,000 | -88.0% | 4,459 | -88.1% | 0.07% | -87.6% |
| Q4 2013 | $3,869,000 | +1132.2% | 37,367 | +538.0% | 0.55% | +1039.6% |
| Q3 2013 | $314,000 | +26.6% | 5,857 | +4.7% | 0.05% | +9.1% |
| Q2 2013 | $248,000 | – | 5,596 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |